GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the lhn fragment of botulinum neurotoxin type D, mutant H233Y E230Q

Analyse Crystal structure of the lhn fragment of botulinum neurotoxin type D, mutant… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5BQN
Type
protein
Length
838 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Botulinum neurotoxin type D,BOTULINUM neurotoxin type D
EC
3.4.24.69
UniProt
P19321
Pockets
10 · best druggability 0.83

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABotulinum neurotoxin type D,BOTULINUM neurotoxin type D (EC 3.4.24.69)protein83841% helix, 14% strandP19321

Ligands and binding sites

  • EPE · 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

10 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18320.830.85108empty
24590.670.7944empty
34590.660.7845empty
4930.630.8922empty
53560.590.7738empty

Modifications

Observed in the structure: 1 disulfide (disulfide).

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.